DK172032B1 - (S)-enantiomere glutaramidderivater og disse forbindelser til anvendelse som lægemidler samt farmaceutiske præparater indeholdende disse forbindelser og (S)-enantiomere glutarsyrederivater, der er anvendelige som mellemprodukter ved fremstilling af disse forbindelser - Google Patents
(S)-enantiomere glutaramidderivater og disse forbindelser til anvendelse som lægemidler samt farmaceutiske præparater indeholdende disse forbindelser og (S)-enantiomere glutarsyrederivater, der er anvendelige som mellemprodukter ved fremstilling af disse forbindelser Download PDFInfo
- Publication number
- DK172032B1 DK172032B1 DK240889A DK240889A DK172032B1 DK 172032 B1 DK172032 B1 DK 172032B1 DK 240889 A DK240889 A DK 240889A DK 240889 A DK240889 A DK 240889A DK 172032 B1 DK172032 B1 DK 172032B1
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- formula
- ester
- methoxyethoxy
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Detergent Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8811873 | 1988-05-19 | ||
GB888811873A GB8811873D0 (en) | 1988-05-19 | 1988-05-19 | Therapeutic agents |
Publications (3)
Publication Number | Publication Date |
---|---|
DK240889D0 DK240889D0 (da) | 1989-05-18 |
DK240889A DK240889A (da) | 1989-11-20 |
DK172032B1 true DK172032B1 (da) | 1997-09-22 |
Family
ID=10637176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK240889A DK172032B1 (da) | 1988-05-19 | 1989-05-18 | (S)-enantiomere glutaramidderivater og disse forbindelser til anvendelse som lægemidler samt farmaceutiske præparater indeholdende disse forbindelser og (S)-enantiomere glutarsyrederivater, der er anvendelige som mellemprodukter ved fremstilling af disse forbindelser |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP0342850B1 (hu) |
JP (1) | JPH072699B2 (hu) |
KR (1) | KR920000561B1 (hu) |
CN (1) | CN1015361B (hu) |
AT (1) | ATE76399T1 (hu) |
AU (1) | AU602813B2 (hu) |
CA (1) | CA1331197C (hu) |
CS (1) | CS274502B2 (hu) |
DD (1) | DD283772A5 (hu) |
DE (1) | DE68901582D1 (hu) |
DK (1) | DK172032B1 (hu) |
EG (1) | EG19007A (hu) |
ES (1) | ES2037418T3 (hu) |
FI (1) | FI93541C (hu) |
GB (1) | GB8811873D0 (hu) |
GR (1) | GR3004968T3 (hu) |
HU (1) | HU205067B (hu) |
IE (1) | IE60724B1 (hu) |
IL (1) | IL90267A (hu) |
MX (1) | MX16067A (hu) |
MY (1) | MY104735A (hu) |
NO (1) | NO173647C (hu) |
NZ (1) | NZ229186A (hu) |
PH (1) | PH26740A (hu) |
PL (1) | PL154813B1 (hu) |
PT (1) | PT90584B (hu) |
SU (1) | SU1766251A3 (hu) |
YU (1) | YU47973B (hu) |
ZA (1) | ZA893696B (hu) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8812597D0 (en) * | 1988-05-27 | 1988-06-29 | Pfizer Ltd | Therapeutic agents |
GB8820844D0 (en) * | 1988-09-05 | 1988-10-05 | Pfizer Ltd | Therapeutic agents |
GB9000725D0 (en) * | 1990-01-12 | 1990-03-14 | Pfizer Ltd | Therapeutic agents |
EP0644176B1 (en) * | 1993-09-22 | 1995-11-15 | Pfizer Limited | Hydrogenation |
US7468390B2 (en) | 2002-01-17 | 2008-12-23 | Novartis Ag | Methods of treatment and pharmaceutical composition |
AR057882A1 (es) | 2005-11-09 | 2007-12-26 | Novartis Ag | Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra |
US8993631B2 (en) | 2010-11-16 | 2015-03-31 | Novartis Ag | Method of treating contrast-induced nephropathy |
RU2667643C2 (ru) | 2012-08-24 | 2018-09-21 | Новартис Аг | Ингибиторы nep для лечения заболеваний, характеризующихся увеличением или ремоделированием предсердия |
WO2017033128A1 (en) | 2015-08-25 | 2017-03-02 | Novartis Ag | Biphenyl-substitued 4-amino-butyric acid derivatives and their use in the synthesis of nep inhibitors |
WO2017072636A1 (en) | 2015-10-29 | 2017-05-04 | Cadila Healthcare Limited | Pharmaceutical synergistic combination |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR880007441A (ko) * | 1986-12-11 | 1988-08-27 | 알렌 제이.스피겔 | 스피로-치환된 글루타르아미드 이뇨제 |
-
1988
- 1988-05-19 GB GB888811873A patent/GB8811873D0/en active Pending
-
1989
- 1989-05-09 AT AT89304698T patent/ATE76399T1/de not_active IP Right Cessation
- 1989-05-09 ES ES198989304698T patent/ES2037418T3/es not_active Expired - Lifetime
- 1989-05-09 DE DE8989304698T patent/DE68901582D1/de not_active Expired - Fee Related
- 1989-05-09 EP EP89304698A patent/EP0342850B1/en not_active Expired - Lifetime
- 1989-05-11 IL IL90267A patent/IL90267A/xx not_active IP Right Cessation
- 1989-05-16 MY MYPI89000654A patent/MY104735A/en unknown
- 1989-05-17 HU HU892460A patent/HU205067B/hu not_active IP Right Cessation
- 1989-05-17 DD DD89328675A patent/DD283772A5/de not_active IP Right Cessation
- 1989-05-17 MX MX1606789A patent/MX16067A/es unknown
- 1989-05-17 CA CA000599911A patent/CA1331197C/en not_active Expired - Fee Related
- 1989-05-17 PL PL1989279491A patent/PL154813B1/pl unknown
- 1989-05-17 ZA ZA893696A patent/ZA893696B/xx unknown
- 1989-05-17 PT PT90584A patent/PT90584B/pt not_active IP Right Cessation
- 1989-05-17 CS CS296589A patent/CS274502B2/cs not_active IP Right Cessation
- 1989-05-17 SU SU4614002A patent/SU1766251A3/ru active
- 1989-05-18 AU AU34904/89A patent/AU602813B2/en not_active Ceased
- 1989-05-18 NZ NZ229186A patent/NZ229186A/xx unknown
- 1989-05-18 YU YU102289A patent/YU47973B/sh unknown
- 1989-05-18 DK DK240889A patent/DK172032B1/da not_active IP Right Cessation
- 1989-05-18 IE IE161389A patent/IE60724B1/en not_active IP Right Cessation
- 1989-05-18 JP JP1125479A patent/JPH072699B2/ja not_active Expired - Fee Related
- 1989-05-18 NO NO892002A patent/NO173647C/no not_active IP Right Cessation
- 1989-05-18 FI FI892386A patent/FI93541C/fi not_active IP Right Cessation
- 1989-05-19 CN CN89103437A patent/CN1015361B/zh not_active Expired
- 1989-05-19 KR KR1019890006691A patent/KR920000561B1/ko not_active IP Right Cessation
- 1989-05-21 EG EG25089A patent/EG19007A/xx active
- 1989-06-12 PH PH38643A patent/PH26740A/en unknown
-
1992
- 1992-06-18 GR GR920401302T patent/GR3004968T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH05310664A (ja) | ビアリール置換4−アミノ酪酸アミド | |
SK283663B6 (sk) | Spôsob prípravy kyseliny (S)-3-(aminometyl)-5-metylhexánovej | |
DK172032B1 (da) | (S)-enantiomere glutaramidderivater og disse forbindelser til anvendelse som lægemidler samt farmaceutiske præparater indeholdende disse forbindelser og (S)-enantiomere glutarsyrederivater, der er anvendelige som mellemprodukter ved fremstilling af disse forbindelser | |
JPH0725723B2 (ja) | N−アルキル化α−アミノ酸の合成方法 | |
OA10518A (en) | Pyrrolidinyl hydroxamic acid compounds and their production process | |
JPH04230358A (ja) | α−メルカプトアルキルアミンの新規なN−置換誘導体、それらの製造法及び中間体、それらの薬剤としての使用並びにそれらを含有する組成物 | |
JPH02306947A (ja) | キラルβ―アミノ酸の製造方法 | |
US5210276A (en) | Phenylethanolamino- and phenylethanolaminomethyl-tetralines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them | |
JP3187905B2 (ja) | ラセミおよび光学活性1,2,3,4−テトラヒドロイソキノリン−3−カルボン酸およびその前駆体の製造方法 | |
JPH02256655A (ja) | 光学活性なスレオージヒドロキシフェニルセリン誘導体の製造方法 | |
JP2001521498A (ja) | O−(3−アミノ−2−ヒドロキシ−プロピル)−ヒドロキシミック酸ハロゲン化物の製造方法 | |
JPH069515A (ja) | 光学活性ホモ−β−アミノ酸の製造方法 | |
KR100503443B1 (ko) | 광학적으로 활성인 세티리진 또는 그의 염의 제조방법 | |
US6433174B1 (en) | Process for producing novel naphthyridine derivatives | |
US5106970A (en) | Optically active 4-morpholino-2-(1-naphthylmethyl)-4-oxobutyric acid 2'-hydroxy-1,1'binaphthalen-2-yl | |
JP2000239274A (ja) | 新規ナフチリジン誘導体の製造法 | |
US5151544A (en) | Intermediates in the preparation of chiral spirofluorenehydantoins | |
JPS62132846A (ja) | 4−アミノブタン酸誘導体及びその製法 | |
SU722480A3 (ru) | Способ получени -аминоалкоксициклоалканов или их солей | |
JP4524841B2 (ja) | 光学活性アミノ酸エステル酒石酸アミドおよびその製造法 | |
WO2023174810A1 (en) | A process for the synthesis of ( r)-2-(( tert-butoxycarbonyl)amino)-3-(diethoxyphosphoryl)propanoic acid or of phosphonate derivatives thereof | |
JPH10291979A (ja) | 1,2,3,4−テトラヒドロイソキノリン−3−カルボン酸ターシャリーブチルアミドの製造方法 | |
JPH07304746A (ja) | 新規ベンゾアゼピンカルボン酸誘導体 | |
JP2003321429A (ja) | フェニルアラニン誘導体の製法およびその合成中間体 | |
JPS6155496B2 (hu) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
PBP | Patent lapsed |
Country of ref document: DK |